BANETTE

Actavis Holdco Us, Inc.

Application Filed: 2014-06-20
Trademark Application Details
Trademark Logo BANETTE
606
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED
Research OneLook Acronym Finder
Serial Number86316014
Mark Drawing Code4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Attorney NameMatthew O. Brady
Attorney Docket NumberBAN001
Law Office AssignedL30
Employee NameSTRINGER, DANIEL S

Timeline

2014-06-20Application Filed
2014-11-25Published for Opposition
2017-08-01Location: INTENT TO USE SECTION
2018-02-26Abandon
2018-02-26Status: Dead/Abandoned
2018-07-08Transaction Date

Trademark Applicants & Owners

Owner: ACTAVIS HOLDCO US, INC.
Address400 INTERPACE PARKWAY PARSIPPANY DE 07054
Legal Entity TypeCorporation
Legal Entity StateDE

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

MATTHEW O. BRADY
ACTAVIS, INC.
400 INTERPACE PKWY
PARSIPPANY, NJ 07054-1120

Good, Services, and Codes

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Contraceptive preparations; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the sensory organs; Pharmaceuticals and medicines for the central nervous system; Pharmaceuticals and medicines for the urogenital organs; Pharmaceuticals and medicines for the circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular diseases and blood pressure; Pharmaceuticals preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antimicrobial preparations for inhibiting microbiological decomposition in pharmaceuticals

Trademark Filing History

DescriptionDateEvent Coding
NEW APPLICATION ENTERED IN TRAM2014-06-241 NWAP I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2014-06-282 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER2014-09-243 DOCK D:Assigned to Examiner
EXAMINERS AMENDMENT -WRITTEN2014-10-014 CNEA R:Renewal
EXAMINERS AMENDMENT E-MAILED2014-10-015 GNEA F:First Action
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED2014-10-016 GNEN O:Outgoing Correspondence
EXAMINER'S AMENDMENT ENTERED2014-10-017 XAEC I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER2014-10-018 CNSA P:
ASSIGNED TO LIE2014-10-229 ALIE A:Allowance for Publication
LAW OFFICE PUBLICATION REVIEW COMPLETED2014-10-2210 PREV O:Outgoing Correspondence
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2014-11-0511 NONP E:E-Mail
PUBLISHED FOR OPPOSITION2014-11-2512 PUBO A:Allowance for Publication
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2014-11-2513 NPUB E:E-Mail
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2015-01-2014 NOAM E:E-Mail
TEAS EXTENSION RECEIVED2015-07-2015 EEXT I:Incoming Correspondence
EXTENSION 1 FILED2015-07-2016 EXT1 S:
EXTENSION 1 GRANTED2015-07-2017 EX1G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2015-07-2218 EXRA E:E-Mail
TEAS EXTENSION RECEIVED2016-01-2019 EEXT I:Incoming Correspondence
CASE ASSIGNED TO INTENT TO USE PARALEGAL2016-02-2320 AITU A:Allowance for Publication
EXTENSION 2 FILED2016-01-2021 EXT2 S:
EXTENSION 2 GRANTED2016-02-2422 EX2G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2016-02-2523 EXRA E:E-Mail
TEAS EXTENSION RECEIVED2016-07-1924 EEXT I:Incoming Correspondence
EXTENSION 3 FILED2016-07-1925 EXT3 S:
EXTENSION 3 GRANTED2016-08-0126 EX3G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2016-08-0227 EXRA E:E-Mail
TEAS EXTENSION RECEIVED2017-01-2028 EEXT I:Incoming Correspondence
EXTENSION 4 FILED2017-01-2029 EXT4 S:
EXTENSION 4 GRANTED2017-01-2030 EX4G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2017-01-2431 EXRA E:E-Mail
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP2017-02-2232 ASGN I:Incoming Correspondence
TEAS EXTENSION RECEIVED2017-07-1933 EEXT I:Incoming Correspondence
CASE ASSIGNED TO INTENT TO USE PARALEGAL2017-08-0134 AITU A:Allowance for Publication
EXTENSION 5 FILED2017-07-1935 EXT5 S:
EXTENSION 5 GRANTED2017-08-0136 EX5G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2017-08-0237 EXRA E:E-Mail
ABANDONMENT - NO USE STATEMENT FILED2018-02-2638 ABN6 S:
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED2018-02-2639 MAB6 O:Outgoing Correspondence
UNDELIVERABLE MAIL - NO ACTION TAKEN2018-04-0640 UNDN O:Outgoing Correspondence

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed